ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $927,930 | -44.3% | 6,804 | -38.3% | 0.13% | -38.2% |
| Q1 2024 | $1,665,893 | +99.3% | 11,020 | +66.1% | 0.21% | +30.1% |
| Q4 2023 | $835,678 | +510.4% | 6,635 | +353.8% | 0.16% | +307.5% |
| Q3 2023 | $136,902 | +105.1% | 1,462 | +95.5% | 0.04% | +90.5% |
| Q2 2023 | $66,759 | -19.2% | 748 | -3.0% | 0.02% | -25.0% |
| Q1 2023 | $82,667 | +19.4% | 771 | +36.0% | 0.03% | 0.0% |
| Q4 2022 | $69,248 | +28.2% | 567 | +9.0% | 0.03% | +21.7% |
| Q3 2022 | $54,000 | – | 520 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |